- Trials with a EudraCT protocol (391)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (8)
391 result(s) found for: Neutropenia.
Displaying page 1 of 20.
EudraCT Number: 2005-002136-10 | Sponsor Protocol Number: GRIFO-A | Start Date*: 2005-07-08 | |||||||||||
Sponsor Name:ISTITUTO GIANNINA GASLINI | |||||||||||||
Full Title: Comparison between once-per-cycle peg-Filgrastim and daily injection r-Hu-G-CSF in chemotherapy-induced neutropenia treatment and peripheral blood progenitor cells mobilization in childhood. | |||||||||||||
Medical condition: chemotherapy-induced neutropenia treatment peripheral blood progenitor cells mobilization | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001118-32 | Sponsor Protocol Number: EP06-401 | Start Date*: 2011-05-25 | |||||||||||||||||||||
Sponsor Name:Sandoz GmbH | |||||||||||||||||||||||
Full Title: Twelve-month study on the immunogenicity, safety, and efficacy of Zarzio®/Filgrastim HEXAL® in patients with severe chronic neutropenia | |||||||||||||||||||||||
Medical condition: Severe chronic neutropenia (i.e. congenital neutropenia, cyclic neutropenia and chronic idiopathic neutropenia) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) SE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-007161-20 | Sponsor Protocol Number: BK0023-02C | Start Date*: 2009-01-08 | |||||||||||
Sponsor Name:BIO-KER S.R.L | |||||||||||||
Full Title: Comparable efficacy and safety profiles of daily injection of BK0023 and filgrastim (Neupogen®) in chemotherapy-induced neutropenia: a multinational, multicenter, investigator blind, randomised, pa... | |||||||||||||
Medical condition: Chemotherapy induced Neutropenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BG (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003166-14 | Sponsor Protocol Number: RGB-02-101 | Start Date*: 2013-11-20 | ||||||||||||||||
Sponsor Name:Gedeon Richter Plc. | ||||||||||||||||||
Full Title: Multiple, fixed-dose, comparative efficacy and safety evaluation of RGB-02 and Neulasta® in patients undergoing chemotherapy treatment known to induce neutropenia. | ||||||||||||||||||
Medical condition: Neutropenia and febrile neutropenia in patients being treated with cytotoxic chemotherapy for malignancy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Elderly | Gender: Female | |||||||||||||||||
Trial protocol: CZ (Completed) HU (Completed) BG (Completed) HR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001549-32 | Sponsor Protocol Number: Caspofungin vs Amfotericina | Start Date*: 2006-03-01 | |||||||||||
Sponsor Name:A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA | |||||||||||||
Full Title: Prospectic, multicentric, randomized, controlled trial for the evaluation of efficacy of Caspofungin vs Amfotericina B liposomiale for the empirical treatment of the FUO in children neutropenic for... | |||||||||||||
Medical condition: Neutropenia (neutrophil count <500/mm3 for at least 10 days persistent fever for at least 72-96 hours, refrectory to the traetment with wide spectrum antibiotic appropriate for high risk pa... | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005402-53 | Sponsor Protocol Number: 2-2-6 STUDY | Start Date*: 2008-01-09 | |||||||||||
Sponsor Name:Academisch Ziekenhuis Maastricht | |||||||||||||
Full Title: Primary G-CSF prophylaxis during the first two cycles only or throughout all chemotherapy cycles in breast cancer patients at risk of febrile neutropenia | |||||||||||||
Medical condition: Prophylaxis of febrile neutropenia during chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000087-34 | Sponsor Protocol Number: XM22-08 | Start Date*: 2015-06-05 | ||||||||||||||||
Sponsor Name:Merckle GmbH | ||||||||||||||||||
Full Title: An Open-Label, Randomized, Active-Controlled, Multicenter Study to Evaluate the Efficacy, Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Lipegfilgrastim 100 μg/kg B... | ||||||||||||||||||
Medical condition: Neutropenia in pediatric patients diagnosed with Ewing family of Tumors or rhabdomyosarcoma receiving chemotherapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Completed) LT (Completed) SK (Completed) CZ (Completed) BG (Completed) DE (Ongoing) ES (Completed) RO (Completed) PL (Completed) BE (Completed) HR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003094-10 | Sponsor Protocol Number: SPI-GCF-12-201 | Start Date*: 2014-01-16 | |||||||||||
Sponsor Name:Spectrum Pharmaceuticals | |||||||||||||
Full Title: Phase 2, Open-Label, Dose-Ranging Study of HM10460A or Pegfilgrastim use for the Management of Neutropenia in Patients with Breast Cancer who are Candidates for Adjuvant and Neoadjuvant Chemotherap... | |||||||||||||
Medical condition: Management of Neutropenia in Patients with Breast Cancer who are Candidates for Adjuvant and Neoadjuvant Chemotherapy with the Docetaxel + Cyclophosphamide (TC) Regimen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) PL (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000266-64 | Sponsor Protocol Number: PEGF/USV/P3/003 | Start Date*: 2015-06-18 | ||||||||||||||||
Sponsor Name:USV Limited | ||||||||||||||||||
Full Title: A Randomised, Multi-Centre, Assessor-Blinded, Active-Controlled, Parallel Group, Equivalence Phase III Study Comparing the Safety and Efficacy of USV Pegfilgrastim and Neulasta® in Breast Cancer Pa... | ||||||||||||||||||
Medical condition: Duration of Sever Neutropenia and incidence of febrile neutropenia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: HU (Completed) BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003469-24 | Sponsor Protocol Number: SPI-GCF-302 | Start Date*: 2017-03-14 | |||||||||||
Sponsor Name:Spectrum Pharmaceuticals, Inc. | |||||||||||||
Full Title: Randomized, OpEn-Label, Active-ContrOl Trial of SPI-2012 (Eflapegrastim) Versus Pegfilgrastim in the Management of Chemotherapy-Induced Neutropenia in Early-Stage BReast Cancer Patients Receiving D... | |||||||||||||
Medical condition: Management of Neutropenia in Patients with Breast Cancer who receiving Chemotherapy with the Docetaxel + Cyclophosphamide | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002693-20 | Sponsor Protocol Number: GX‐G3_NHL_2/CGX14001 | Start Date*: 2016-01-21 | |||||||||||
Sponsor Name:Ilkogen Ilac San. ve Tic. A.S. | |||||||||||||
Full Title: A randomized, parallel group, multi-centre phase-2 study of GX-G3 compared with pegfilgrastim as an adjunct to chemotherapy in patients with Non-Hodgkin’s Lymphoma | |||||||||||||
Medical condition: Neutropenia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003276-39 | Sponsor Protocol Number: 09072012 | Start Date*: 2013-01-09 | ||||||||||||||||
Sponsor Name:Hæmatologisk afdeling, Roskilde Sygehus, Region Sjælland | ||||||||||||||||||
Full Title: Investigation of the value of Iron and Bonemarrow stimulation in differential diagnostic of Polycythemia Vera and Essential Thrombocytosis | ||||||||||||||||||
Medical condition: Polycythemia Vera Essential thrombocytosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000394-36 | Sponsor Protocol Number: GCF071 | Start Date*: 2007-09-07 | |||||||||||
Sponsor Name:Hospira UK Ltd | |||||||||||||
Full Title: A Phase III randomised, multicentre, double-blind, therapeutic equivalence study of biosimilar G-CSF (PLIVA/Mayne filgrastim) versus Neupogen (filgrastim-Amgen) in subjects receiving doxorubicin an... | |||||||||||||
Medical condition: This study is designed to demonstrate the therapeutic equivalence of PLIVA/Mayne filgrastim and Neupogen for the reduction in duration of neutropenia and the incidence of febrile neutropenia, in su... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) LV (Completed) PL (Completed) ES (Completed) BG (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004539-18 | Sponsor Protocol Number: PGCN-001 | Start Date*: 2018-08-27 | |||||||||||
Sponsor Name:Prolong Pharmaceuticals, LLC | |||||||||||||
Full Title: A Phase 2, Open-Label, Multicenter, Efficacy, Safety, Tolerability, and Pharmacokinetic Study of ANF–Rho™ in Patients with Chronic Neutropenia | |||||||||||||
Medical condition: Chronic neutropenia | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001772-55 | Sponsor Protocol Number: XM02-ONC-201 | Start Date*: 2015-01-26 | |||||||||||
Sponsor Name:TEVA Pharmaceutical Industries Ltd | |||||||||||||
Full Title: A Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Efficacy, and Immunogenicity of Daily Subcutaneous Administration of 5 μg/kg tbo-filgrastim... | |||||||||||||
Medical condition: Chemotherapy induced Neutropenia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BG (Completed) PL (Completed) RO (Completed) HR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003610-25 | Sponsor Protocol Number: CT-MT001-2-2015-1 | Start Date*: 2015-12-09 | |||||||||||
Sponsor Name:Myelo Therapeutics GmbH | |||||||||||||
Full Title: A randomised, double-blind, placebo-controlled, parallel-design, multi-centre study to investigate the efficacy to reduce chemotherapy-induced neutropenia (CIN), effects on the haematopoietic syste... | |||||||||||||
Medical condition: Chemotherapy-induced neutropenia (CIN) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001179-60 | Sponsor Protocol Number: CABASTY | Start Date*: 2019-10-21 |
Sponsor Name:A.R.T.I.C (Association pour la Recherche de Thérapeutiques Innovantes en Cancérologie) | ||
Full Title: Randomized multicenter, phase III trial evaluating the safety of 2 schedules of cabazitaxel (bi-weekly versus tri-weekly) plus prednisone in elderly men (≥ 70 years) with metastatic castration-resi... | ||
Medical condition: Metastatic castration-resistant prostate cancer (mCRPC) | ||
Disease: | ||
Population Age: Elderly | Gender: Male | |
Trial protocol: NL (Completed) DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005034-36 | Sponsor Protocol Number: KWI-300-104 | Start Date*: 2008-07-15 | |||||||||||
Sponsor Name:Apotex Inc. | |||||||||||||
Full Title: A non comparative, multicentre, repeat dose safety in use study of Neukine® (Filgrastim) in patients receiving chemotherapy known to induce neutropenia | |||||||||||||
Medical condition: Febrile neutropenia in breast cancer patients undergoing TAC chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) AT (Completed) PL (Completed) BG (Completed) GR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002388-33 | Sponsor Protocol Number: ZKSJ0086 | Start Date*: 2016-09-05 |
Sponsor Name:Friedrich-Schiller-University Jena | ||
Full Title: Therapeutic drug monitoring (TDM) for personalized antibiotic treatment with piperacillin-tazobactam (PipTaz) in patients with febrile neutropenia after myelo-suppressive cytostatic chemotherapy | ||
Medical condition: Patients with febrile neutropenia after myelo-suppressive chemotherapy treated with piperacillin/tazobactam | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-000533-36 | Sponsor Protocol Number: GETH-PRODORI-2011-01 | Start Date*: 2011-06-28 | |||||||||||
Sponsor Name:Grupo Español de Trasplante Hematopoyético (GETH) | |||||||||||||
Full Title: Estudio prospectivo, abierto, multicéntrico, de brazo único para evaluar la farmacocinética/farmacodinamia, factibilidad y seguridad de Doripenem como monoterapia en infusión prolongada (1000 mg en... | |||||||||||||
Medical condition: Tratamiento empírico de la neutropenia febril | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.